华康生物医学(08622)完成收购湖南可悦生物科技91%股权

智通财经
26 Jun

智通财经APP讯,华康生物医学(08622)发布公告,有关收购湖南可悦生物科技有限公司91%股权,股权转让协议下所有条件已获达成,收购事项已于2025年6月26日按股权转让协议约定完成交割。

交割完成后,公司间接持有目标公司91%股权,目标公司剩余9%股权由执行董事张玉静女士直接持有。据此,目标公司成为公司非全资附属公司,其财务业绩将纳入集团合并财务报表。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10